Published in:
01-01-2019 | Gastrointestinal
A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion
Published in: European Radiology | Issue 1/2019
Login to get accessAbstract
Objectives
Most existing models that are in use to model hepatic function through assessment of hepatic gadoxetic acid enhancement kinetics do not consider quantitative measures of gadoxetic excretion. We developed a model that allows a simultaneous quantitation of uptake and excretion of liver specific contrast agents. The aim was to improve the assessment of hepatic synthetic function, and provide quantitative measures of hepatic excretion function.
Methods
Sixteen patients underwent dynamic T1-weighted turbo gradient echo imaging at 1.5 T prior and after bolus injection of gadoxetic acid at 0.1 ml/kg. DCE-images were obtained for 30 min after injection. A dual-inlet two-compartment model was then used to fit the measured liver signal values. Four tissue parameters (extracellular volume fraction, arterial flow fraction, uptake rate and excretion half-time) were extracted for each liver segment.
Results
The proposed model provided a good fit to acquired data. Mean values for arterial flow fraction (0.08+-0.04), extracellular volume (0.20±0.08) and uptake rate (4.02 ±1.32 /100 ml/min) were comparable to those obtained with the conventional model (0.08±0.05, 0.21±0.12, and 4.93±1.74), but exhibited significantly less variation and improved fit quality.
Conclusions
The proposed model is more accurate than existing conventional models and provides an additional excretion parameter.
Key Points
• Models of hepatic contrast agent uptake can be extended to include excretion.
• Including an additional excretion parameter improves accuracy of the model.
• Standard diagnostic sequences can be extended to incorporate the model.